RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Chougule, Mahavir
Item TypeName
Academic Article Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.
Academic Article Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
Academic Article Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.
Academic Article Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
Academic Article EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
Academic Article Translational application of nano delivery systems: emerging cancer therapy.
Academic Article Theranostic tumor homing nanocarriers for the treatment of lung cancer.
Academic Article Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Academic Article Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Academic Article Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.
Academic Article The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.
Academic Article Bioreducible Poly(Amino Ethers) Based mTOR siRNA Delivery for Lung Cancer.
Academic Article Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.
Academic Article Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
Concept Antineoplastic Agents
Concept Antineoplastic Agents, Phytogenic
Search Criteria
  • Antineoplastic Agents
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support